Beate C Sydora1, Hilary Fast, Sandy Campbell, Nese Yuksel, Jacqueline E Lewis, Sue Ross. 1. 1Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada 2John W. Scott Health Sciences Library, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada 3Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada 4Department of Family Medicine, University of Calgary, Calgary, Canada.
Abstract
OBJECTIVE: The Menopause-Specific Quality of Life (MENQOL) questionnaire was developed as a validated research tool to measure condition-specific QOL in early postmenopausal women. We conducted a comprehensive scoping review to explore the extent of MENQOL's use in research and clinical practice to assess its value in providing effective, adequate, and comparable participant assessment information. METHODS: Thirteen biomedical and clinical databases were systematically searched with "menqol" as a search term to find articles using MENQOL or its validated derivative MENQOL-Intervention as investigative or clinical tools from 1996 to November 2014 inclusive. Review articles, conference abstracts, proceedings, dissertations, and incomplete trials were excluded. Additional articles were collected from references within key articles. Three independent reviewers extracted data reflecting study design, intervention, sample characteristics, MENQOL questionnaire version, modifications and language, recall period, and analysis detail. Data analyses included categorization and descriptive statistics. RESULTS: The review included 220 eligible papers of various study designs, covering 39 countries worldwide and using MENQOL translated into more than 25 languages. A variety of modifications to the original questionnaire were identified, including omission or addition of items and alterations to the validated methodological analysis. No papers were found that described MENQOL's use in clinical practice. CONCLUSIONS: Our study found an extensive and steadily increasing use of MENQOL in clinical and epidemiological research over 18 years postpublication. Our results stress the importance of proper reporting and validation of translations and variations to ensure outcome comparison and transparency of MENQOL's use. The value of MENQOL in clinical practice remains unknown.
OBJECTIVE: The Menopause-Specific Quality of Life (MENQOL) questionnaire was developed as a validated research tool to measure condition-specific QOL in early postmenopausal women. We conducted a comprehensive scoping review to explore the extent of MENQOL's use in research and clinical practice to assess its value in providing effective, adequate, and comparable participant assessment information. METHODS: Thirteen biomedical and clinical databases were systematically searched with "menqol" as a search term to find articles using MENQOL or its validated derivative MENQOL-Intervention as investigative or clinical tools from 1996 to November 2014 inclusive. Review articles, conference abstracts, proceedings, dissertations, and incomplete trials were excluded. Additional articles were collected from references within key articles. Three independent reviewers extracted data reflecting study design, intervention, sample characteristics, MENQOL questionnaire version, modifications and language, recall period, and analysis detail. Data analyses included categorization and descriptive statistics. RESULTS: The review included 220 eligible papers of various study designs, covering 39 countries worldwide and using MENQOL translated into more than 25 languages. A variety of modifications to the original questionnaire were identified, including omission or addition of items and alterations to the validated methodological analysis. No papers were found that described MENQOL's use in clinical practice. CONCLUSIONS: Our study found an extensive and steadily increasing use of MENQOL in clinical and epidemiological research over 18 years postpublication. Our results stress the importance of proper reporting and validation of translations and variations to ensure outcome comparison and transparency of MENQOL's use. The value of MENQOL in clinical practice remains unknown.
Authors: Kai Triebner; Ane Johannessen; Cecilie Svanes; Bénédicte Leynaert; Bryndís Benediktsdóttir; Pascal Demoly; Shyamali C Dharmage; Karl A Franklin; Joachim Heinrich; Mathias Holm; Deborah Jarvis; Eva Lindberg; Jesús Martínez Moratalla Rovira; Nerea Muniozguren Agirre; José Luis Sánchez-Ramos; Vivi Schlünssen; Svein Magne Skulstad; Steinar Hustad; Francisco J Rodriguez; Francisco Gómez Real Journal: PLoS One Date: 2020-06-30 Impact factor: 3.240
Authors: S E Aapkes; L H P Bernts; A P van den Berg; M van den Berg; H Blokzijl; A E P Cantineau; M D A van Gastel; R J de Haas; P Kappert; R U Müller; F Nevens; R Torra; A Visser; J P H Drenth; R T Gansevoort Journal: BMC Gastroenterol Date: 2022-02-25 Impact factor: 3.067